These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

988 related articles for article (PubMed ID: 19253492)

  • 1. A determination of topics for health technology assessment in Thailand: making decision makers involved.
    Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy making and roles of health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S88-99. PubMed ID: 19253491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thai health technology assessment guideline development.
    Teerawattananon Y; Chaikledkaew U
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S11-5. PubMed ID: 19253483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the scope of health technology assessment and types of health economic evaluation.
    Tanvejsilp P; Ngorsuraches S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.
    Gagnon MP; Sánchez E; Pons JM
    Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health technology assessment.
    Papatheofanis FJ
    Q J Nucl Med; 2000 Jun; 44(2):105-11. PubMed ID: 10967621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
    Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
    Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making health technology assessment information available for decision making: the development of a Thai database.
    Kapol N; Maitreemit P; Chalongsuk R; Amrumpai Y; Sribundit N; Thavorncharoensap M; Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S8-10. PubMed ID: 19253482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making sensible rationing: the use of economic evidence and the need for methodological standards.
    Tangcharoensathien V; Kamolratanakul P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S4-7. PubMed ID: 19253481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment development in China.
    Chen Y; Banta D; Tang Z
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():202-9. PubMed ID: 19575825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of strengths, weaknesses, opportunities, and threats in the development of a health technology assessment program in Turkey.
    Kahveci R; Meads C
    Int J Technol Assess Health Care; 2008; 24(2):235-40. PubMed ID: 18400128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.